메뉴 건너뛰기




Volumn , Issue , 2009, Pages

Acute retinal arterial occlusion after intravenous administration of bevacizumab

Author keywords

[No Author keywords available]

Indexed keywords


EID: 84859525213     PISSN: None     EISSN: 1757790X     Source Type: Journal    
DOI: 10.1136/bcr.01.2009.1478     Document Type: Article
Times cited : (2)

References (8)
  • 1
    • 0018330381 scopus 로고
    • Cilioretinal arteries and retinal arterial occlusion
    • Brown GC, Shields JA. Cilioretinal arteries and retinal arterial occlusions. Arch Ophthalmol 1979; 97: 84-92. (Pubitemid 9051060)
    • (1979) Archives of Ophthalmology , vol.97 , Issue.1 , pp. 84-92
    • Brown, G.C.1    Shield, J.A.2
  • 2
    • 0024638883 scopus 로고
    • Branch retinal-artery obstruction: A review of 2001 eyes
    • Ros MA, Magargal LE, Uram M. Branch retinal-artery obstruction: A review of 2001 eyes. Ann Ophthalmol 1989; 21: 103-7.
    • (1989) Ann Ophthalmol , vol.21 , pp. 103-107
    • Ros, M.A.1    Magargal, L.E.2    Uram, M.3
  • 3
    • 6344289580 scopus 로고    scopus 로고
    • Retinal artery obstruction
    • In: Ry an SJ, Schachat AP, Murphy RP, eds. 3rd ed. Vol 2. Medical retina. St Louis, Missouri: Mosby
    • Ry an SJ, Schachat AP, Murphy RP Sharma S, Brown GC. Retinal artery obstruction. In: Ry an SJ, Schachat AP, Murphy RP, eds. Retina, 3rd ed. Vol 2. Medical retina. St Louis, Missouri: Mosby, 2001: 1350-67.
    • (2001) Retina , pp. 1350-1367
    • Ry An, S.J.1    Schachat, A.P.2    Murphy, R.P.3    Sharma, S.4    Brown, G.C.5
  • 4
    • 34547700399 scopus 로고    scopus 로고
    • Bevacizumab in non small cell lung cancer
    • Sandler A. Bevacizumab in non small cell lung cancer. Clin Cancer Res 2007; 13: 4613-6.
    • (2007) Clin Cancer Res , vol.13 , pp. 4613-4616
    • Sandler, A.1
  • 5
    • 33750296920 scopus 로고    scopus 로고
    • The International Intravitreal Bevacizumab Safety Survey: Using the internet to assess drug safety worldwide
    • DOI 10.1136/bjo.2006.099598
    • Fung AE, Rosenf eld PJ, Reichel E. The international intrav itreal bevacizumab safety survey : using the internet to assess drug safety worldwide. Br J Ophthalmol 2006; 90: 1344-9. (Pubitemid 44702055)
    • (2006) British Journal of Ophthalmology , vol.90 , Issue.11 , pp. 1344-1349
    • Fung, A.E.1    Rosenfeld, P.J.2    Reichel, E.3
  • 7
    • 20144372969 scopus 로고    scopus 로고
    • Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration: Twelve-week results of an uncontrolled open-label clinical study
    • DOI 10.1016/j.ophtha.2005.02.007, PII S0161642005002976
    • Michels S, Rosenf eld PJ, Puliaf ito CA, et al. Systemic bevacizumab (Avastin) therapy for neovascular age-related macular degeneration. Twelv e-week results of an uncontrolled open-label clinical study. Ophthalmology 2005; 112: 1035-47. (Pubitemid 40797459)
    • (2005) Ophthalmology , vol.112 , Issue.6 , pp. 1035-1047
    • Michels, S.1    Rosenfeld, P.J.2    Puliafito, C.A.3    Marcus, E.N.4    Venkatraman, A.S.5
  • 8
    • 34250359084 scopus 로고    scopus 로고
    • Intravitreal bevacizumab for neovascular glaucoma following central retinal artery occlusion
    • Vatav uk Z, Bencic G, Mandic Z. Intrav itreal bevacizumab for neovascular glaucoma following central retinal artery occlusion. Eur J Ophthalmol 2007; 17: 269-71. (Pubitemid 46918117)
    • (2007) European Journal of Ophthalmology , vol.17 , Issue.2 , pp. 269-271
    • Vatavuk, Z.1    Bencic, G.2    Mandic, Z.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.